Literature DB >> 12954587

Successful treatment of malignant pheochromocytoma with combination chemotherapy containing anthracycline.

M Nakane, S Takahashi, I Sekine, I Fukui, M Koizumi, K Kage, Y Ito, K Aiba, N Horikoshi, K Hatake, Y Ishikawa, E Ogata.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12954587     DOI: 10.1093/annonc/mdg358

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Patient with inoperable pheochromocytoma.

Authors:  D Brancíková; Z Mechl; Z Adam; E Jandáková; Z Pavlovský; V Válek; Z Andrašina
Journal:  Curr Oncol       Date:  2015-06       Impact factor: 3.677

Review 2.  Current progress and future challenges in the biochemical diagnosis and treatment of pheochromocytomas and paragangliomas.

Authors:  G Eisenhofer; G Siegert; J Kotzerke; S R Bornstein; K Pacak
Journal:  Horm Metab Res       Date:  2008-05       Impact factor: 2.936

3.  Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway.

Authors:  Ying Pang; Chunzhang Yang; Jan Schovanek; Herui Wang; Petra Bullova; Veronika Caisova; Garima Gupta; Katherine I Wolf; Gregg L Semenza; Zhengping Zhuang; Karel Pacak
Journal:  Oncotarget       Date:  2017-04-04

4.  Updated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma/paraganglioma.

Authors:  Gabriele Parenti; Benedetta Zampetti; Elena Rapizzi; Tonino Ercolino; Valentino Giachè; Massimo Mannelli
Journal:  J Oncol       Date:  2012-07-17       Impact factor: 4.375

5.  High-throughput screening for the identification of new therapeutic options for metastatic pheochromocytoma and paraganglioma.

Authors:  Alessio Giubellino; Uma Shankavaram; Petra Bullova; Jan Schovanek; Yaqin Zhang; Min Shen; Nikita Patel; Abdel Elkahloun; Min-Jung Lee; Jane Trepel; Marc Ferrer; Karel Pacak
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.